You are viewing archived content
Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.
Figure TDI-1. Trend in estimated number of new clients entering treatment by primary drug used, from 2002 to 2006 [see all figures in this series...]
Part (ii) Numbers of clients by primary drug
Notes:
Missing data were interpolated by assigning for the respective country the EU average year-on-year trend from available data. Altogether, 9 % of data points and 16 % of the number of clients were interpolated.
Countries included: Bulgaria, Czech Republic, Denmark, Germany, Ireland, Greece, Spain, Cyprus, Latvia, Hungary, Malta, Netherlands, Portugal, Romania, Slovakia, Slovenia, Finland, Sweden, United Kingdom.
Italian data was excluded because before 2005 it was not compatible with the TDI definition.
French data was omitted due to changes in reporting structures in 2006.
Related links:
Statistical bulletin 2007: none
See also ‘General notes for interpreting data’ on the Explanatory notes and help page
Sources:
Reitox national reports 2007 - ST. 34 and ST.04 - New clients
(see the help page for information about formats etc.)